Study of DM5167 in Patients With Advanced Solid Tumors
NCT07101601
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Breast Cancer
Interventions
DRUG:
DM5167
Sponsor
DIGMBIO